PMC Links for Books (Select 4440764) - PMC

Select item 84380461.

Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials

Michel Sabe, Nan Zhao, Alessio Crippa, Stefan Kaiser

NPJ Schizophr. 2021; 7: 43. Published online 2021 Sep 13. doi: 10.1038/s41537-021-00171-2

PMCID:: PMC8438046

Article PDF–1.5M

Select item 79847422.

Ziprasidone Associated Neuroleptic Malignant Syndrome

Jeffrey D. Bell, Chancen Hall, Justin Sandall

Kans J Med. 2021; 14: 82–83. Published online 2021 Mar 19. doi: 10.17161/kjm.vol1411970

PMCID:: PMC7984742

Article PDF–105K

Select item 79539123.

Case Report: Ziprasidone induced neuroleptic malignant syndrome

Yub Raj Sedhai, Alok Atreya, Prabin Phuyal, Soney Basnyat, Sagar Pokhrel

Version 1. F1000Res. 2021; 10: 124. Published online 2021 Feb 17. doi: 10.12688/f1000research.51094.1

PMCID:: PMC7953912

Article PDF–669K

Select item 67180094.

Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment

Randall K. Hoover, Harry Alcorn, Jr, Laura Lawrence, Susan K. Paulson, Megan Quintas, David R. Luke, Sue K. Cammarata

J Clin Pharmacol. 2018 Jun; 58(6): 814–822. Published online 2018 Mar 26. doi: 10.1002/jcph.1077

PMCID:: PMC6718009

Article PDF–508K

Select item 63985505.

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease

John R. Younce, Albert A. Davis, Kevin J. Black

J Parkinsons Dis. 2019; 9(1): 63–71. Prepublished online 2018 Nov 21. Published online 2019 Feb 5. doi: 10.3233/JPD-181448

PMCID:: PMC6398550

Article PDF–131K

Select item 63649996.

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

T.D. Girard, M.C. Exline, S.S. Carson, C.L. Hough, P. Rock, M.N. Gong, I.S. Douglas, A. Malhotra, R.L. Owens, D.J. Feinstein, B. Khan, M.A. Pisani, R.C. Hyzy, G.A. Schmidt, W.D. Schweickert, R.D. Hite, D.L. Bowton, A.L. Masica, J.L. Thompson, R. Chandrasekhar, B.T. Pun, C. Strength, L.M. Boehm, J.C. Jackson, P.P. Pandharipande, N.E. Brummel, C.G. Hughes, M.B. Patel, J.L. Stollings, G.R. Bernard, R.S. Dittus, E.W. Ely

N Engl J Med. Author manuscript; available in PMC 2019 Jun 27.

Published in final edited form as: N Engl J Med. 2018 Dec 27; 379(26): 2506–2516. Published online 2018 Oct 22. doi: 10.1056/NEJMoa1808217

PMCID:: PMC6364999

Article PDF–825K

Select item 62991877.

Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis

Davide Martino, Vikram Karnik, Sydney Osland, Thomas R. E. Barnes, Tamara M. Pringsheim

Can J Psychiatry. 2018 Nov; 63(11): 730–739. Published online 2018 May 14. doi: 10.1177/0706743718777392

PMCID:: PMC6299187

Article PDF–435K

Select item 62452918.

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review

In Hee Shim, Won-Myong Bahk, Young Sup Woo, Bo-Hyun Yoon

Clin Psychopharmacol Neurosci. 2018 Nov; 16(4): 376–382. Published online 2018 Nov 30. doi: 10.9758/cpn.2018.16.4.376

PMCID:: PMC6245291

Article PDF–255K

Select item 62349649.

Ziprasidone, haloperidol and clonazepam intramuscular administration in the treatment of agitation symptoms in Chinese patients with schizophrenia: A network meta-analysis

Liang Su, Zheng Lu, Shenxun Shi, Yifeng Xu

Gen Psychiatr. 2018; 31(2): e000016. Published online 2018 Nov 10. doi: 10.1136/gpsych-2018-000016

PMCID:: PMC6234964

Article PDF–1.1M

Select item 616213910.

Hyponatremia in Association With Second-Generation Antipsychotics: A Systematic Review of Case Reports

Sarah Naz Ali, Lydia A. Bazzano

Ochsner J. 2018 Fall; 18(3): 230–235. Published online Fall 2018. doi: 10.31486/toj.17.0059

PMCID:: PMC6162139

Article PDF–145K

Select item 595201111.

Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders

Wilbert S. Aronow, Tatyana A. Shamliyan

Ann Transl Med. 2018 Apr; 6(8): 147. doi: 10.21037/atm.2018.03.17

PMCID:: PMC5952011

Article PDF–475K

Select item 566685512.

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome

Sang Won Jeon, Yong-Ku Kim

Int J Mol Sci. 2017 Oct; 18(10): 2174. Published online 2017 Oct 18. doi: 10.3390/ijms18102174

PMCID:: PMC5666855

Article PDF–246K

Select item 549979013.

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

Marco Solmi, Andrea Murru, Isabella Pacchiarotti, Juan Undurraga, Nicola Veronese, Michele Fornaro, Brendon Stubbs, Francesco Monaco, Eduard Vieta, Mary V Seeman, Christoph U Correll, André F Carvalho

Ther Clin Risk Manag. 2017; 13: 757–777. Published online 2017 Jun 29. doi: 10.2147/TCRM.S117321

PMCID:: PMC5499790

Article PDF–529K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 13

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity